Unknown

Dataset Information

0

Immunity After Childhood Vaccinations in Perinatally HIV-exposed Children With and Without HIV Infection in Latin America.


ABSTRACT: BACKGROUND:Perinatally HIV-infected (PHIV) children are at risk for under-vaccination and poor vaccine response at 4 years of age. Childhood vaccine coverage and immune response were compared between PHIV and HIV-exposed uninfected (HEU) children in Latin America and the Caribbean. METHODS:PHIV and HEU children were enrolled prospectively at 15 sites from 2002 to 2009. Full vaccination by age 4 years was defined as: 3 hepatitis B virus vaccine doses; 4 tetanus toxoid-containing vaccine doses; 3 doses of Haemophilus influenzae type b vaccine by age 12 months or ?1 dose given after age 12 months; one measles-containing vaccine dose; one rubella-containing vaccine dose. Immunity was defined by serum antibody titer. Fisher exact test (for categorical measures) and t test (for continuous measures) were used for comparisons. RESULTS:Among 519 children seen at age 4 years, 191 had serum specimens available (137 PHIV, 54 HEU). Among those with specimens available, 29.3% initiated combination antiretroviral therapy (cART) <12 months of age, 30.9% initiated at ?12 months of age, and 39.8% had not received cART by the time they were seen at 4 years of age. At 4 years of age, 59.9% were on PI-containing cART (cART/PI), and 20.4% were on no ART. PHIV children were less likely than HEU children to be fully vaccinated for tetanus (55.5% vs. 77.8%, P = 0.005) and measles and rubella (both 70.1% vs. 94.4%, P < 0.001). Among those fully vaccinated, immunity was significantly lower among PHIV than HEU for all vaccines examined: 20.9% versus 37.8% for hepatitis B virus (P = 0.04), 72.0% versus 90.5% for tetanus (P = 0.02), 51.4% versus 68.8% for H. influenzae type b (P = 0.05), 80.2% versus 100% for measles (P < 0.001) and 72.9% versus 98.0% for rubella (P < 0.001) vaccine, respectively. CONCLUSIONS:Compared with HEU, PHIV children were significantly less likely to be immune to vaccine-preventable diseases when fully vaccinated. Strategies to increase immunity against vaccine-preventable diseases among PHIV require further study.

SUBMITTER: Succi RCM 

PROVIDER: S-EPMC5849487 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Immunity After Childhood Vaccinations in Perinatally HIV-exposed Children With and Without HIV Infection in Latin America.

Succi Regina C M RCM   Krauss Margot R MR   Harris D Robert DR   Machado Daisy M DM   de Moraes-Pinto Maria I MI   Mussi-Pinhata Marisa M MM   Pavia Ruz Noris N   Pierre Russell B RB   Kolevic Roca Lenka A LA   Joao Esaú E   Foradori Irene I   Scotta Marcelo C MC   Hazra Rohan R   Siberry George K GK  

The Pediatric infectious disease journal 20180401 4


<h4>Background</h4>Perinatally HIV-infected (PHIV) children are at risk for under-vaccination and poor vaccine response at 4 years of age. Childhood vaccine coverage and immune response were compared between PHIV and HIV-exposed uninfected (HEU) children in Latin America and the Caribbean.<h4>Methods</h4>PHIV and HEU children were enrolled prospectively at 15 sites from 2002 to 2009. Full vaccination by age 4 years was defined as: 3 hepatitis B virus vaccine doses; 4 tetanus toxoid-containing va  ...[more]

Similar Datasets

| S-EPMC6387791 | biostudies-literature
| S-EPMC3410657 | biostudies-literature
| S-EPMC6800591 | biostudies-literature
| S-EPMC4817559 | biostudies-literature
| S-EPMC8192432 | biostudies-literature
| S-EPMC6748241 | biostudies-literature
| S-EPMC4907464 | biostudies-literature
| S-EPMC6522268 | biostudies-literature
| S-EPMC5576211 | biostudies-literature
| S-EPMC5854364 | biostudies-literature